Skip to search formSkip to main contentSkip to account menu

gemtuzumab

Known as: gemtuzumab [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

9 relations
Acute myelomonocytic leukemiaDrug AllergyPregnancy

Broader (4)

AminoglycosidesAntibodies, Monoclonal, HumanizedAntineoplastic AgentsImmunotoxins

Narrower (2)

CMA 676Gemtuzumab ozogamicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Therapeutic Advances in First-Line Management of Acute Myeloid Leukemia.
Over the past several years, drug approvals for first-line treatment of acute myeloid leukemia have changed the landscape from a… 
2016
2016
Medullar toxicity after prolonged nitrous oxide exposure: an unexpected cause of bone marrow failure post allogeneic transplant
Medullar toxicity after prolonged nitrous oxide exposure: an unexpected cause of bone marrow failure post allogeneic transplant 
2016
2016
Risk Factors for Human Papilloma Virus Reactivation in the Genital Tract of Female Stem Cell Transplant Survivors
2012
2012
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 
2011
2011
Can cancer clinical trials be fixed?
As oncology drug after oncology drug fails to achieve accelerated approval, sponsors are seeking other ways to speed trials… 
Review
2011
Review
2011
Complications of monoclonal antibody therapy.
iNfusioN reaCTioNs An infusion reaction may range from mild to lethal. The severity is given a rating on a scale of one (mild) to… 
2008
2008
Clofarabine-Induced Remission In Relapsed Pediatric Acute Myelogenous Leukemia
2007
2007
Efficacy and safety of gemtuzumab ozogamicin(mylotarg)-based regimens in patients with CD33-positive refractory leukemia
Objective:To evaluate the efficacy and safety of gemtuzumab ozogamicin(mylotarg)-based regimen.Methods:Eleven patients with… 
2006
2006
Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?
Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity? 
2005
2005
t(11;14) does not predict long-term survival in myeloma
immune-mediated process. IVIG is widely used in patients with autoimmune thrombocytopenic purpura by blockade of the Fc receptors… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)